Inventor
BUZZETTI FRANCO
IT30 patents
⚠️ This page may combine multiple inventors who share the name “BUZZETTI FRANCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ERBA CARLO SPA
19 patentsUS5397787AMar 14, 1995
Vinylene-azaindole derivatives
ERBA CARLO SPA191 citations96
US5409949AApr 25, 1995
Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith
ERBA CARLO SPA65 citations95
US5374652ADec 20, 1994
2-oxindole compounds which are useful as tyrosine kinase inhibitors
ERBA CARLO SPA96 citations95
US4808616AFeb 28, 1989
6-substituted androsta-1,4-diene-3,17-diones
ERBA CARLO SPA71 citations95
US5627207AMay 6, 1997
Arylethenylene compounds which are useful as tyrosine kinase inhibitors
ERBA CARLO SPA21 citations92
US5488057AJan 30, 1996
2-oxindole compounds which have useful tyrosine kinase activity
ERBA CARLO SPA25 citations92
US4904650AFeb 27, 1990
Substituted androsta-1,4-diene-3,17-diones
ERBA CARLO SPA36 citations92
US5576330ANov 19, 1996
Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
ERBA CARLO SPA43 citations91
US5502044AMar 26, 1996
Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
ERBA CARLO SPA15 citations74
US5130472AJul 14, 1992
Total synthesis of erbstatin analogs
ERBA CARLO SPA9 citations73
US5122537AJun 16, 1992
Arylvinylamide derivatives and pharmaceutical use
ERBA CARLO SPA10 citations73
US4824830AApr 25, 1989
6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation
ERBA CARLO SPA14 citations73
US4822528AApr 18, 1989
4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation
ERBA CARLO SPA16 citations73
US5656654AAug 12, 1997
Arylidene and heteroarylidene oxindole derivatives and process for their preparation
ERBA CARLO SPA9 citations72
US5436235AJul 25, 1995
3-aryl-glycidic ester derivatives
ERBA CARLO SPA6 citations71
US4810423AMar 7, 1989
1,2-beta-methylene-4-substituted androstene-3,17-dione derivatives and process for their preparation
ERBA CARLO SPA2 citations63
US5587385ADec 24, 1996
Arylidene-heterocyclic derivatives and process for their preparation
ERBA CARLO SPA2 citations60
US5457097AOct 10, 1995
Androst-4-eno[4,5-b]pyrrole derivatives
ERBA CARLO SPA1 citations52
US5639884AJun 17, 1997
Arylidene-heterocyclic derivatives and process for their preparation
ERBA CARLO SPA0 citations51
PHARMACIA SPA
4 patentsUS5840745ANov 24, 1998
Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
PHARMACIA SPA91 citations96
US5663346ASep 2, 1997
Substituted azaindolylidene compounds and process for their preparation
PHARMACIA SPA30 citations92
US5719135AFeb 17, 1998
Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
PHARMACIA SPA19 citations81
US5652250AJul 29, 1997
N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives and process for their preparation
PHARMACIA SPA5 citations62
PHARMACIA & UPJOHN SPA
4 patentsUS5965563AOct 12, 1999
Aryl and heteroaryl purine compounds
PHARMACIA & UPJOHN SPA27 citations92
US6057326AMay 2, 2000
Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
PHARMACIA & UPJOHN SPA9 citations74
US6147073ANov 14, 2000
Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors
PHARMACIA & UPJOHN SPA5 citations61
US5905149AMay 18, 1999
Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors
PHARMACIA & UPJOHN SPA5 citations61